Genotype and Lifetime Burden of Disease in Hypertrophic CardiomyopathyCarolyn Y. Ho, Sharlene M. Day, Euan A. Ashley et al.|Circulation|2018Cited by 837
Myosin Sequestration Regulates Sarcomere Function, Cardiomyocyte Energetics, and Metabolism, Informing the Pathogenesis of Hypertrophic CardiomyopathyChristopher N. Toepfer, Christine E. Seidman, Amanda C. Garfinkel et al.|Circulation|2020Cited by 327
Valsartan in early-stage hypertrophic cardiomyopathy: a randomized phase 2 trialCarolyn Y. Ho, Eugene Braunwald, Sharlene M. Day et al.|Nature Medicine|2021Cited by 132
Prediction of Sarcomere Mutations in Subclinical Hypertrophic CardiomyopathyGabriella Captur, James Moon, Luís R. Lopes et al.|Circulation Cardiovascular Imaging|2014Cited by 111
Association of Race With Disease Expression and Clinical Outcomes Among Patients With Hypertrophic CardiomyopathyLauren A. Eberly, Neal K. Lakdawala, Sharlene M. Day et al.|JAMA Cardiology|2019Cited by 109